Tutte le pubblicazioni

Study of lncRNAs expression profile in the response to biological drugs in Psoriatic Arthritis: MEG3 could be a potential genomic biomarker of therapy efficacy. De Benedittis, G., D’Antonio, A., Latini, A., (…), Chimenti, M.S., Borgiani, P. 2024    International Immunopharmacology 134, 112239


Evaluation of diagnostic and therapeutic delay in patients with rheumatoid arthritis and psoriatic arthritis Iacovantuono, M., Ferrigno, S., Conigliaro, P., (…), Bergamini, A., Chimenti, M.S. 2024 Reumatismo 76(1), pp. 35-42


The rs11568820 Variant in the Promoter Region of Vitamin D Receptor Gene Is Associated with Clinical Remission in Rheumatoid Arthritis Patients Receiving Tumor Necrosis Factor Inhibitors Latini, A., De Benedittis, G., Conigliaro, P., (…), Ciccacci, C., Borgiani, P. 2024 Genes 15(2),234
 
Impact of biological therapy in reducing the risk of arthritis development in inflammatory bowel diseases Fatica, M., Monosi, B., Conigliaro, P., (…), Calabrese, E., Chimenti, M.S. 2024 RMD Open 10(1),e003820
 
The steroid-sparing effect of JAK inhibitors across multiple patient populations Conigliaro, P., Minerba, C., Vendola, A, Bergamini, A., Chimenti, M.S.    2024    Frontiers in Immunology 15,1376476


Risankizumab Efficacy in Synovitis, Acne, Pustulosis, Hyperostosis, and Osteitis (SAPHO) Remission: A Case Report on Rheumatologic and Dermatologic Disease Manifestations with Literature Review Ferraioli, M., Fiannacca, L., Greco, E., (…), Bergamini, A., Chimenti, M.S. 2024         Case Reports in Immunology 2024,9076852


Clinical and imaging findings in enteropathic spondyloarthritis with special emphasize in diagnostic delay: a cross-sectional study Conigliaro, P., D’Antonio, A., Wlderk, A., (…), Bergamini, A., Chimenti, M.S.    2024    Therapeutic Advances in Chronic Disease 15


Subclinical microvascular changes in ANCA-vasculitides: the role of optical coherence tomography angiography and nailfold capillaroscopy in the detection of disease-related damage Triggianese, P., D’Antonio, A., Nesi, C., (…), Chimenti, M., Cesareo, M.  2023    Orphanet Journal of Rare Diseases 18(1),184


Relationship between retinal microvascular impairment and subclinical atherosclerosis in SLE Ferrigno, S., Conigliaro, P., Rizza, S., (…), Chimenti, M.S., Cesareo, M.      2023    Lupus Science and Medicine 10(2),e 000977


Rheumatologist’s Perspective on Non-Infectious Uveitis: Patterns from Tertiary Referral Rheumatologic Clinics in Italy Triggianese, P., Fatica, M., Caso, F., (…), Cantarini, L., Chimenti, M.S.           2023    International Journal of Molecular Sciences 24(11), 9690


Failure and multiple failure for disease modifying antirheumatic drugs in rheumatoid arthritis: Real-life evidence from a tertiary referral center in Italy Triggianese, P., Bergamini, A., Chimenti, M.S., (…), D’Erme, L., Fonti, G.L.2023    PLoS ONE 18 (2 February), e0281213


How Has Molecular Biology Enhanced Our Undertaking of axSpA and Its Management Fatica, M., D’Antonio, A., Novelli, L., (…), Perricone, C., Chimenti, M.S.    2023    Current Rheumatology Reports 25(1), pp. 12-33


Baricitinib effectiveness in patients with alopecia universalis and rheumatoid arthritis         Dattola, A., Pensa, C., Chimenti, M.S., (…), Campione, E., Bianchi, L.   2022  Italian Journal of Dermatology and Venereology 157(6), pp. 535-536


A multilocus genetic study evidences the association of autoimmune-related genes with Psoriatic Arthritis in Italian patients       De Benedittis, G., Latini, A., Conigliaro, P., (…), Chimenti, M.S., Borgiani, P.   2022    Immunobiology 227(4),152232


What’s new and what’s next for biological and targeted synthetic treatments in psoriatic arthritis? Sunzini, F., D’Antonio, A., Fatica, M., (…), Bergamini, A., Chimenti, M.S.   2022    Expert Opinion on Biological Therapy 22(12), pp. 1545-1559


Effectiveness and safety of secukinumab in axial spondyloarthritis: a 24-month prospective, multicenter real-life study Ramonda, R., Lorenzin, M., Chimenti, M.S., (…), Foti, R., Carletto, A.         2022    Therapeutic Advances in Musculoskeletal Disease


Micronutrients deficiencies in patients with spondylarthritis: the potential immunometabolic crosstalk in disease phenotype        Triggianese, P., Caso, F., Morte, D.D., (…), Bergamini, A., Chimenti, M.S. 2022    European Review for Medical and Pharmacological Sciences 26(6), pp. 2025-2035


Reliability of a re-usable wireless Epidermal temperature sensor in real conditions   Miozzi, C., Amendola, S., Bergamini, A., Marrocco, G.     2017    2017 IEEE 14th International Conference on Wearable and Implantable Body Sensor Networks, BSN 2017 7936016, pp. 95-98


Inappropriateness of diagnostic imaging examinations in the inpatient setting: a case study research           Squillaci, E., Bolacchi, F., Scaggiante, J., (…), Garaci, F., Floris, R.           2017 Radiologia Medica 122(3), pp. 221-227


Clinical trial of wireless epidermal temperature sensors: Preliminary results  Miozzi, C., Amendola, S., Bergamini, A., Marrocco, G.     2017     IFMBE Proceedings 65, pp. 1041-1044


Expression of the receptor activator of nuclear factor-kB ligand in peripheral blood mononuclear cells in patients with acute charcot neuroarthropathy Bergamini, A., Bolacchi, F., Pesce, C.D., (…), Mondillo, M.T., Squillaci, E.         2016    International Journal of Medical Sciences13(11), pp. 875-880


Clinical and radiological signs of ABPA associated with airways infection with Aspergillus in the absence of specific IgE          Sunzini, F., Barbato, C., Canofari, C., (…), Perricone, R., Bergamini, A.    2016    European annals of allergy and clinical immunology 48(5), pp. 202-204


Expression of immunoglobulin-like transcript 4 as an inhibitory receptor in patients with psoriatic arthritis Chimenti, M.S., Bergamini, A., Triggianese, P., (…), Perricone, C., Perricone, R.         2016    Journal of International Medical Research44(1_suppl), pp. 22-27


Synovial fluid from patients with rheumatoid arthritis modulates monocyte cell-surface phenotype Chimenti, M.S., Conigliaro, P., Triggianese, P., (…), Perricone, R., Bergamini, A.        2016    Journal of International Medical Research 44(1_suppl), pp. 15-21


F protein increases CD4+CD25+ T cell population in patients with chronic hepatitis C Hashempour, T., Bamdad, T., Bergamini, A., (…), Ajorloo, M., Merat, S.     2015    Pathogens and Disease73(4),ftv022


Pre-treatment staging of multiple myeloma patients: Comparison of whole-body diffusion weighted imaging with whole-body T1-weighted contrast-enhanced imaging Squillaci, E., Bolacchi, F., Altobelli, S., (…), Cantonetti, M., Simonetti, G.       2015    Acta Radiologica56(6), pp. 733-738 21


Analysis of exhaled breath fingerprints and volatile organic compounds in COPD   Cazzola, M., Segreti, A., Capuano, R., (…), Di Natale, C., D’Amico, A.        2015    COPD Research and Practice 1(1),7


Downregulation of immunoglobulin-like transcript-4 (ILT4) in patients with psoriatic arthritis Bergamini, A., Chimenti, M.S., Baffari, E., (…), Perricone, C., Perricone, R. 2014    PLoS ONE 9(3),e92018


Comparative evaluation of percutaneous laser and radiofrequency ablation in patients with HCC smaller than 4 cm       Orlacchio, A., Bolacchi, F., Chegai, F., (…), Angelico, M., Simonetti, G. 2014          Radiologia Medica 119(5), pp. 298-308


Serum soluble ST2 as diagnostic marker of systemic inflammatory reactive syndrome of bacterial etiology in children Calò Carducci, F.I., Aufiero, L.R., Folgori, L., (…), Finocchi, A., D’argenio, P.      2014    Pediatric Infectious Disease Journal 33(2), pp. 199-203


Proton magnetic resonance spectroscopy in the evaluation of patients with acute Charcot neuro-osteoarthropathyBolacchi, F., Uccioli, L., Masala, S., (…), Simonetti, G., Bergamini, A.   2013    European Radiology 23(10), pp. 2807-2813


Upregulation of the inhibitory receptor ILT4 in monocytes from septic patients        Baffari, E., Fiume, D., Caiazzo, G., (…), Leonardis, F., Bergamini, A.      2013    Human Immunology 74(10), pp. 1244-1250


A new natural history of charcot foot: Clinical evolution and final outcome of stage 0 charcot neuroarthropathy in a tertiary referral diabetic foot clinic Ruotolo, V., Di Pietro, B., Giurato, L., Bergamini, A., Uccioli, L. 2013    Clinical Nuclear Medicine 38(7), pp. 506-509


Vitamin D3 modulates T lymphocyte responses in hepatitis C virus-infected liver transplant recipients      Almerighi, C., Bergamini, A., Lionetti, R., (…), Tisone, G., Angelico, M.        2012    Digestive and Liver Disease 44(1), pp. 67-73


COPD identification by the analysis of breath with an electronic nose           Capuano, R., Santonico, M., Martinelli, E., (…), Di Natale, C., D’Amico, A.        2011    AIP Conference Proceedings 1362, pp. 19-20


Uccioli L, Sinistro A, Almerighi C, Ciaprini C, Cavazza A, Giurato L, Ruotolo V, Spasaro F, Vainieri E, Rocchi G, Bergamini A. Pro-inflammatory modulation of the surface and cytokine phenotype of monocytes in patients with acute Charcot foot. Diabetes Care 2010 33:350-355.


Natoli S, Fontana C, Favaro M, Bergamini A, Testore GP, Minelli S, Bossa MC, Casapulla M, Broglio G, Beltrame A, Cudillo L, Cerretti R, Leonardis F.Characterization of coagulase-negative staphylococcal isolates from blood with reduced susceptibility to glycopeptides and therapeutic options. BMC Infect Dis. 2009 Jun 4;9:83


Butini S, Brindisi M, Cosconati S, Marinelli L, Borrelli G, Coccone SS, Ramunno A, Campiani G, Novellino E, Zanoli S, Samuele A, Giorgi G, Bergamini A, Mattia MD, Lalli S, Galletti B, Gemma S, Maga G. Specific Targeting of Highly Conserved Residues in the HIV-1 Reverse Transcriptase Primer Grip Region. 2. Stereoselective Interaction to Overcome the Effects of Drug Resistant Mutations. J Med Chem. 2009;52:1224-8.


Almerighi C, Sinistro A, Cavazza A, Ciaprini C, Rocchi G, Bergamini A. 1alpha,25-Dihydroxyvitamin D3 inhibits CD40L-induced pro-inflammatory and immunomodulatory activity in Human Monocytes. Cytokine. 2009;45(3):190-7.


Lvova L, Martinelli E, Dini F, Bergamini A, Paolesse R, Di Natale C, D’Amico A. Clinical analysis of human urine by means of potentiometric Electronic tongue. Talanta. 2009;77:1097-104.


Sinistro A, Almerighi C, Ciaprini C, Natoli S, Sussarello E, Di Fino S, Calò-Carducci F, Rocchi G, Bergamini A. Downregulation of CD40 ligand response in monocytes from sepsis patients. Clin Vaccine Immunol. 2008;15:1851-8. 


Orlacchio A, Bolacchi F, Cadioli M, Bergamini A, Angelico M, Cozzolino V, Simonetti G. Evaluation of chronic hepatitis C severity by 3 Tesla 1H spectroscopy. AJR Am J Roentgenol 2008;190:1331-9.


Regina GL, Coluccia A, Piscitelli F, Bergamini A, Sinistro A, Cavazza A, Maga G, Samuele A, Zanoli S, Novellino E, Artico M, Silvestri R. Indolyl aryl sulfones as HIV-1 non-nucleoside reverse transcriptase inhibitors: role of two halogen atoms at the indole ring in developing new analogues with improved antiviral activity. J Med Chem. 2007;50:5034-5038. 


Sinistro A, Caprini C, Natoli S, Sussarello E, Calò Carducci F, Almerighi C, Capozzi M, Bolacchi F, Rocchi G, Bergamini A. Lipopolysaccharide Desensitizes Monocytes-Macrophages to CD40L Stimulation. Immunology 2007;122:362-370.


Bolacchi F, Sinistro A, Ciaprini C, Demin F, Capozzi M, Calò Carducci F, Tommasi C, Drapeau CMJ, Rocchi G, and Bergamini A. Increased hepatitis C virus (HCV)-specific CD4+CD25+ regulatory T lymphocytes and reduced HCV-specific CD4+ T cell response in HCV-infected patients with normal versus abnormal alanine aminotransferase levels. Clin Exp Immunol, 2006;144:188-196


Lavecchia A, Costi R, Artico M, Miele G, Novellino E, Bergamini A, Crespan E, Maga G, Di Santo R. Arylthiopyrrole (AThP) derivatives as non-nucleoside HIV-1 reverse transcriptase inhibitors: synthesis, structure-activity relationships, and docking studies (part 2).ChemMedChem. 2006;1:1379-90


Di Santo R, Costi R, Artico M, Miele G, Lavecchia A, Novellino E, Bergamini A, Cancio R, Maga G. Arylthiopyrrole (AThP) derivatives as non-nucleoside HIV-1 reverse transcriptase inhibitors: synthesis, structure-activity relationships, and docking studies (part 1).ChemMedChem. 2006;1:1367-78


De Martino G, La Regina G, Ragno R, Coluccia A, Bergamini A, Ciaprini C, Sinistro A, Maga G, Crespan E, Artico M, Silvestri R. Indolyl aryl sulphones as HIV-1 non-nucleoside reverse transcriptase inhibitors: synthesis, biological evaluation and binding mode studies of new derivatives at indole-2-carboxamide. Antivir Chem Chemother. 2006;17:59-77


Ragno R, Coluccia A, La Regina G, De Martino G, Piscitelli F, Lavecchia A, Novellino E, Bergamini A, Ciaprini C, Sinistro A, Maga G, Crespan E, Artico M, Silvestri R. Design, molecular modeling, synthesis, and anti-HIV-1 activity of new indolyl aril sulfones. Novel derivates of the indole-2-carboxamide. J Med Chem 2006;49:3172-3184


Fattorusso C, Gemma S, Butini S, Huleatt P, Catalanotti B, Persico M, De Angelis M, Fiorini I, Nacci V, Ramunno A, Rodriquez M, Greco G, Novellino E, Bergamini A, Marini S, Coletta M, Maga G, Spadari S, Campiani G. Specific Targeting Highly Conserved Residues in the HIV-1 Reverse Transcriptase Primer Grip Region. Design, Synthesis, and Biological Evaluation of Novel, Potent, and Broad Spectrum NNRTIs with Antiviral Activity. J Med Chem. 2005;48:7153-7165


De Martino G, La Regina G, Di Pasquali A, Ragno R, Bergamini A, Ciaprini C, Sinistro A, Maga G, Crespan E, Artico M, and Silvestri R. Novel 1-[2-(Diarylmethoxy)ethyl]-2-methyl-5-nitroimidazoles as HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors. A Structure-Activity Relationship Investigation. J Med Chem 2005 30;48:4378-88


Pesce CD, Bolacchi F, Bongiovanni B, Cisotta F, Capozzi M, Diviacco S Quadrifoglio F, Mango R, Novelli G, Mossa G, Esposito C, Ombres D, Rocchi G and Bergamini A. Anti-gene peptide nucleic acid targeted to proviral HIV-1 DNA inhibits in vitro HIV-1 replication. Antiviral Research 2005;66:13-22


Bergamini A, Cepparulo M, Bolacchi F, Araco A, Tisone G, Ombres D, Rocchi G Angelico M. Ribavirin increases mitogen-induced expression of CD40L on CD4+ T cells. Clin Exp Immunol 2002;130:293-299


Bergamini A, Bolacchi F, Pesce CD, Carbone M, Cepparulo M, Rocchi G. Soluble CD40 ligand increases CD4 and CCR5 expression on macrophages and the susceptibility to HIV-1 infection. J Infect Dis 2002;185:1567-77


Maga G, Ramunno A, Nacci V, Locatelli GA, Spadari S, Fiorini I, Baldanti F, Paolucci S, Zavattoni M, Bergamini A, Galletti, Muck S, Hubscher U, Giorgi G, Guiso G, Caccia S, Campiani G.The stereoselective targeting of a specific enzyme-substrate complex is the molecular mechanism for the synergic inhibition of HIV-1 reverse transcriptase by (R)-(-)-PPO464: A novel generation of non-nucleoside inhibitors. J Biol Chem. 2001;276:44653-44662


Bolacchi F, Carbone M, Capozzi M, Ventura L, Cepparulo M, Rocchi G, Bergamini A. Effect of different activation stimuli on the cytokine response of human macrophages to CD40L. Cytokine 2001;16:121-5


Bergamini A, Bolacchi F, Cerasari G, Carvelli C, Faggioli E, Cepparulo M, Demin F, Uccella I, Bongiovanni B, Niutta P, Capozzi M, Lupi M, Piscitelli E, Rocchi G, Angelico M. Lack of evidence for the Th2 predominance in patients with chronic hepatitis C. Clin Exp Immunol 2001;123:451-459


Campiani G, Aiello F, Fabbrini M, Morelli E, Ramunno A, Armaroli S, Nacci V, Garofalo A, Greco G, Novellino E, Maga G, Spadari S, Bergamini A, Capozzi M. Ventura L, Bongiovanni B, Guiso G, Caccia S. Quinoxalinylethylpyridylthioureas (QXPTs) as Potent Non-Nucleoside HIV-1 Reverse Transcriptase (RT) Inhibitors. Further SAR Studies and Identification of a Novel Orally Bioavailable Hydrazine-Based Antiviral Agent J Med Chem 2001;44:305-315


Bergamini A, Bolacchi F, Cepparulo M, Demin F, Uccella I, Bongiovanni B, Ombres D, Angelico F, Liuti A, Hurtova M, Francioso S, Carvelli C, Cerasari G, Angelico M, Rocchi G. Treatment with ribavirin and interferon- reduces interferon- expression in patients with chronic hepatitis C. Clin Exp Immunol 2001;123:459-465


Campiani G, Fabbrini M, Morelli E, Nacci V, Greco G, Novellino E, Maga G, Spadari S, Bergamini A, Faggioli E, Uccella I, Bolacchi F, Marini S, Coletta M, Fracasso C, Caccia S. Non-nucleoside HIV-1 reverse transcriptase inhibitors: synthesis and biological evaluation of novel quinoxalinylethylpyridylthioureas as potent antiviral agents. Antiviral Chem Chemother 2000;11:141-155


Bergamini A, Bolacchi F, Bongiovanni B, Cepparulo M, Ventura L, Capozzi M, Sarrecchia C, Rocchi G. Granulocyte-macrophage colony-stimulating factor regulates cytokine production in cultured macrophages through CD14-dependent and -independent mechanisms. Immunology 2000;101:254-261 


Bergamini A, Bolacchi F, Bongiovanni B, Colizzi V, Cappelli G, Uccella I, Cepparulo M, Capozzi M, Mancino G, Rocchi G. Human immunodeficiency virus type 1 infection modulates the interleukin (IL)-1 and IL-6 responses of human macrophages to CD40 ligand stimulation. J Infect Dis 2000;182:776-84


Campiani G, Morelli E, Fabbrini M, Nacci V, Greco G, Novellino E, Ramunno A, Maga G, Spadari S, Caliendo G, Bergamini A, Faggioli E, Uccella I, Bolacchi F, Marini S, Coletta M Nacca A, Caccia S. Pyrrolbenzoxazepinone derivatives as non-nucleoside HIV-1 RT inhibitors: further structure-activity relationship studies and identification of more potent broad spectrum HIV-1 RT inhibitors with antiviral activity. J Med Chem 1999, 42:4250-4263


Bergamini A, Faggioli E, Bolacchi F, Gessani S, Cappannoli L. Uccella I, Demin F, Capozzi M, Cicconi R, Placido R, Vendetti S, Mancino G, Colizzi V, Rocchi G. Enhanced production of tumor necrosis factor-a and interleukin-6 due to prolonged response to lipopolysaccharide in human macrophages infected in vitro with HIV-1 J Infect Dis 1999;179:832-842 


Bergamini A, Bolacchi F, Faggioli E, Placido R, Vendetti S, Cappannoli L, Ventura L, Cerasari G, Uccella I, Andreoni M, Rocchi G. HIV-1 does not alter in vitro and in vivo IL-10 production by human monocytes and macrophages. Clin Exp Immunol 1998;112:105-111


Bergamini A, Dini L, Baiocchi L, Cappannoli L, Falasca L, Bolacchi F, Capozzi M, Faggioli E, Nistri A, Salanitro A, Ventura L, Rocchi G, Angelico M. Bile acids with differing hydrophilic-hydrophobic properties do not influence cytokine production by human monocytes and murine kupffer cells. Hepatology.1997;25:927-933


Falasca L, Bergamini A, Serafino A, Balabaud C, Dini L. Human Kupffer cell recognition and phagocitosis of apoptotic peripheral blood lymphocytes Exp Cell Res 1996;224:152-162


Bergamini A, Dini L, Ghibelli L, Cepparulo M, Buonanno E, Falasca L, Ventura L, Mancino G, Capozzi M, Placido M, Salanitro A, Cappannoli L, Faggioli E, Stoler A, Rocchi G. Human immunodeficiency virus-induced cell death in cytokine-treated macrophages can be prevented by compounds that inhibit late stages of viral replication. J.Infect.Dis. 1996;173:1367-78


Bergamini A, Ventura L, Mancino G, Capozzi M, Placido R, Salanitro A, Cappannoli L, Faggioli E, Stoler A, Rocchi G. In vitro inhibition of the replication of human immunodeficiency virus type 1 by -mercaptoethylamine (Cysteamine). J Infect Dis 1996;174:214-218


Saladino R, Bernini R, Crestini C, Mincione E, Bergamini A, Marini S, Palamara AT. Studies on the chemistry of pyrimidine derivatives with dimethyldioxirane: synthesis, cytotoxic effect and antiviral activity of new 5,6-oxiranyl-5,6-dihydro and 5-hydroxy-5,6-dihidro-6-substituted uracil derivatives and pyrimidine nucleosides. Tetrahedron 1995;51:7561-7578


Bergamini A, Capozzi M, Cappannoli L, Falasca L, Dini L, Ventura L, Milanese G, Rocchi G. Macrophage colony stimulating factor (M-CSF) enhances the susceptibility of macrophages to infection by HIV and reduces the activity of compounds that inhibit virus binding. Blood 1994;84: 3405-3412


Bergamini A, Capozzi M, Piacentini M. M-CSF stimulation induces cell death in HIV infected multinucleated monocytes. Immunol. Lett.1994;42:35-40


Ghibelli L, Coppola S, Nosseri C, Bergamini A, Beninati S. A protein produced by a monocytic cell lines can induces apoptosis in tumor cells. FEBS Letters 1994;334:35-40


Bergamini A, Capozzi M, Ghibelli L, Dini L, Salanitro A, Milanese G, Wagner T, Beninati S, Pesce CD, Amici C, Rocchi G. Cystamine potently suppresses in vitro HIV replication in acutely and chronically infected human cells. J Clin Invest 1994;93:2251-2257


Perno CF, Bergamini A, Pesce CD, Milanese G, Capozzi M, Thaisrivongs S, Tarpley WG, Zon G, D’Agostini C, Rocchi G, Caliò R: Inhibition of the protease of human immunodeficiency virus blocks replication and infectivity of the virus in chronically-infected macrophages. J Infect Dis 1993;168:1148-56


Bergamini A, Perno CF, Balzarini J, Capozzi M, Marinelli L, Milanese G, Pesce CD, Caliò R, Rocchi G. Selective inhibition of HIV replication by adriamycin in macrophages but not in lymphocytes. AIDS Res Hum. Retroviruses 1992;8:1245-1252


Perno CF, Yarchoan R, Balzarini J, Bergamini A, Milanese G, Pauwels R, De Clercq E, Rocchi G, Caliò R. Different pattern of activity of inhibitors of the human immunodeficiency virus in lymphocytes and monocyte/macrophages. Antiviral Res 1992;40:289-304


Bergamini A, Perno CF, Capozzi M, Mannella E, Salanitro A, Caliò R, Rocchi G. A tetrazolium-based colorimetric assay for quantification of HIV-Induced cytopathogenicity in monocyte-macrophages exposed to macrophage-colony stimulating factor. J Virol Methods 1992;40:275-286


Perno CF, Caliò R, Ercoli L, Bergamini A, Rocchi G. Rational bases for the therapy of HIV-related diseases. Therapy of Infectious Diseases 1990;2-3:99-110